LAMA, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 387
EU - Europa 370
AS - Asia 128
AF - Africa 21
SA - Sud America 1
Totale 907
Nazione #
US - Stati Uniti d'America 384
GB - Regno Unito 110
SE - Svezia 66
CN - Cina 64
IT - Italia 55
SG - Singapore 37
DE - Germania 36
IE - Irlanda 21
CH - Svizzera 17
RU - Federazione Russa 14
FR - Francia 13
IN - India 13
UA - Ucraina 12
GR - Grecia 10
JO - Giordania 8
TG - Togo 8
EE - Estonia 7
ZA - Sudafrica 6
CI - Costa d'Avorio 4
BG - Bulgaria 3
CA - Canada 3
FI - Finlandia 2
NG - Nigeria 2
TR - Turchia 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BR - Brasile 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
SC - Seychelles 1
Totale 907
Città #
Southend 103
Fairfield 48
Chandler 46
Singapore 32
Ashburn 27
Santa Clara 24
Houston 23
Dublin 21
Princeton 19
Ann Arbor 18
Wilmington 17
Bern 16
Seattle 16
Woodbridge 14
Cambridge 13
Beijing 12
Nanchang 9
Westminster 9
Amman 8
Bologna 8
Lomé 8
Medford 8
Padova 8
Boardman 7
Nanjing 7
Jacksonville 6
Shenyang 5
Turin 5
Abidjan 4
Bremen 4
New York 4
Rome 4
San Diego 4
Ancona 3
Berlin 3
Changsha 3
Grafing 3
Sofia 3
Abeokuta 2
Alfonsine 2
Bühl 2
Dearborn 2
Florence 2
Helsinki 2
Istanbul 2
Jianning 2
Jinan 2
Lanzhou 2
Montepulciano 2
Redwood City 2
Riolo Terme 2
San Mateo 2
Taizhou 2
Tianjin 2
Washington 2
Yubileyny 2
Andover 1
Athens 1
Augusta 1
Brussels 1
Cesenatico 1
Davao City 1
Dongguan 1
Eden Prairie 1
Falls Church 1
Frankfurt Am Main 1
Fuzhou 1
Groningen 1
Guangzhou 1
Haikou 1
Hebei 1
Hefei 1
Henderson 1
Jakarta 1
Jiaxing 1
Kunming 1
La Canada Flintridge 1
Leawood 1
Mahé 1
Milan 1
Moscow 1
Mülheim 1
North York 1
Norwalk 1
Paris 1
Parma 1
Prato 1
Provo 1
Qingdao 1
Sacramento 1
Saint Petersburg 1
Sarajevo 1
Shanghai 1
São Paulo 1
Thiene 1
Toronto 1
Viserba 1
Warsaw 1
Winnipeg 1
Wuhan 1
Totale 652
Nome #
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 220
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients 130
Fludarabine, Cytarabine, Idarubicin and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed acute myeloid leukemia (AML): Results of a multicentric phase III Italian study 125
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients 103
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients 99
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients 99
A phase I study of Tipifarnib and Bortezomib in the treatment of poor risk adult acute myeloid leukemia (AML) 88
RASGRP1/APTX ratio is a strong biomarker which predicts response to therapy with Tipifarnib plus Bortezomib in elderly patients with Acute Myeloid Leukemia (AML) 74
Totale 938
Categoria #
all - tutte 2.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202089 0 0 0 0 0 0 0 25 27 12 13 12
2020/202192 25 3 0 5 7 2 2 14 10 10 4 10
2021/2022162 7 5 10 15 18 14 0 9 12 13 22 37
2022/2023205 19 32 6 26 12 16 8 15 41 3 11 16
2023/202457 1 13 3 4 3 11 8 2 5 2 2 3
2024/2025100 10 13 13 10 36 8 8 2 0 0 0 0
Totale 938